Business Context and Reporting Period
Prestige Consumer Healthcare Inc. (PBH) filed a Form 8-K on June 12, 2026, reporting the completion of a major acquisition and the execution of new financing arrangements. The company, incorporated in Delaware, operates in the consumer healthcare sector.
Key Financial Metrics and Transactions
- Acquisition: Completed the purchase of the Breathe Right business and certain other brands from Foundation Consumer Brands, LLC for $1.045 billion in cash.
- Term Loan Facility: Entered into a Term Loan Credit Agreement with proceeds of $1.045 billion used to finance the acquisition. The facility includes an uncommitted second draw option of up to $95.0 million for the pending LaCorium Health acquisition.
- ABL Amendment: Amended its asset-based revolving line of credit to increase aggregate commitments to $225 million and extended the maturity date by five years.
- Interest Rates: Term loans bear interest at Term SOFR plus 2.00% or an alternate base rate (Prime, Fed Funds + 0.50%, or Term SOFR + 1.00%), with floors of 0% and 1.00% respectively.
- Amortization: Quarterly payments equal to 0.25% of the aggregate principal amount.
Material Changes and Covenants
The filing details significant changes to the company's capital structure and debt obligations:
- Debt Structure: The new Term Loan is secured by a perfected security interest in substantially all assets of the Borrower and guarantors. Obligations are unconditionally guaranteed by the Company and certain domestic subsidiaries.
- Mandatory Prepayments: Required upon net cash proceeds from debt issuances, asset sales, and casualty events. Starting fiscal year ending March 31, 2028, mandatory prepayments apply to excess cash flow if the consolidated first lien net leverage ratio exceeds 2.75 to 1.00.
- Covenants: The agreement includes customary affirmative and negative covenants restricting liens, additional indebtedness, dividends, stock repurchases, and asset dispositions.
Outlook, Risks, and Unusual Items
- Future Acquisitions: The company plans to use up to $95.0 million of the new term loan facility to fund the acquisition of LaCorium Health, expected to close in the second quarter of fiscal 2027.
- Financial Reporting: Pro forma financial information and financial statements for the acquired Breathe Right business are not included in this filing. They are expected to be filed within 71 calendar days.
- Risks: The company is subject to customary events of default, including payment defaults, covenant breaches, and change of control, which could trigger acceleration of debt repayment.
Investor Verification Checklist
- Verify the pro forma financial impact of the $1.045 billion acquisition once filed (within 71 days).
- Monitor the company's consolidated first lien net leverage ratio to assess potential mandatory prepayment obligations starting fiscal 2028.
- Confirm the closing timeline and funding status of the LaCorium Health acquisition.
- Review the full text of the Term Loan Credit Agreement and ABL Amendment for specific covenant thresholds and definitions.